Healthcare perspectives from The Economist Intelligence Unit



Hero Carousel


Bringing healthcare to hard-hit areas in Bangladesh




Enhancing patient-centred approaches to optimise early-breast cancer care in New Zealand

New Zealand is amongst the countries with the highest prevalence of breast cancer, affecting one in nine women, and more than 600 deaths every year. The incidence rate exceeds the OECD average and is second only to Australia. According to the WHO New Zealand Cancer profile, the total breast cancer cases per year are expected to increase by 31% and reach 4,584 by 2040 from 3,504 in 2018.

The interrelated epidemic of HPV and HIV in Kenya: Opportunities for health system integration and mobilisation towards a common goal

The global burden of cervical cancer is not spread equally.

Infographic | Realising the value of digital health in Asia and the Pacific

Realising the value of digital health in Asia and the Pacific

Realising the value of digital health in Asia and the Pacific is an Economist Impact report, sponsored by Roche.
The report looks at the landscape of digital health in Asia and the Pacific, the benefits it offers multiple stakeholders, the barriers and challenges to realising its full value, and how the covid-19 pandemic changed the face of digital health seemingly overnight. It presents lessons on how to frame and promote the value proposition for digital health, and also offers key policy takeaways.

Elevating health and wellbeing at a time of global uncertainty

Ahead of the World Health Summit 2022, David Humphreys﹘Economist Impact's global practice lead for health policy﹘and his team of policy experts, clinicians and specialists explore six important themes in healthcare.

Atrial Fibrillation, the most common type of cardiac arrhythmia is on the rise across the Asia-Pacific region

Atrial Fibrillation: Improving care pathways to meet the rising burden across the Asia-Pacific region

Atrial fibrillation (AFib) is the most common cardiac arrhythmia (heart rhythm disorder) among adults. The condition can be diagnosed during routine cardiac screening because of new onset symptoms or as an incidental finding in asymptomatic individuals.

Connecting the Dots: Embedding Progress on Rare Disease into Healthcare

Recent years has seen progress in the diagnosis and care of rare diseases, but health systems have more to do to integrate rare disease care into mainstream care. The good news is that doing so does not involve the wholesale re-invention of existing institutions, structures and processes, so much as adjusting them. 

Equity remains distant: America's mishandling of monkeypox

The monkeypox pandemic highlights how the US has yet to learn from its past mishandling of epidemics. In late 2021, Economist Impact published “Achieving health equity: a roadmap to eliminating disparities”, a report centred on reducing disparities in the US and UK using three disease areas—covid-19, mental health and STIs—to illustrate the cross-cutting nature of these issues. Unfortunately, many of the strategies laid out in that report have not been implemented.

The journey towards health improvement in Argentina: A roadmap for precision medicine

Precision medicine can contribute to many areas of medicine, and is frequently used in oncology, neurology, pneumology and rheumatology. In precision medicine, patient care is tailored to the individual’s genes, environment and lifestyle. This method can identify the most effective treatment for each person. Precision medicine can increase the value of care for patients and payers since identifying and using the most effective treatment for each case can reduce healthcare expenditures.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week